Skip to content

A Community Health Education Intervention for Increasing Community-driven Actions to Reduce the Cancer Burden in Western New York

I Can Join the Fight Against Cancer: An Intervention to Programmatically Build Grassroots Actions to Reduce the Cancer Burden

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06681077
Enrollment
500
Registered
2024-11-08
Start date
2024-11-16
Completion date
2028-11-15
Last updated
2026-09-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Brief summary

This clinical trial evaluates a community health education intervention (I CAN) for increasing community-driven actions to reduce the cancer burden in Western New York. Engaging community members is a critical component of designing impactful programs to reduce the cancer burden. Leaders at the national, state, and local levels have all called for more community partnerships and engagement in design of health intervention and policies. The I CAN intervention is a workshop that includes a presentation outlining key concepts related to social network processes and the cancer burden in Western New York, a structured skill-building activity, and then empowering and motivating activities meant to cultivate momentum and excitement for action. This community health education intervention may be able to provide a formalized process for empowering and facilitating community members to take steps to reduce the community cancer burden.

Detailed description

PRIMARY OBJECTIVES: Phase I - Feasibility and Acceptability - 100 participants to be enrolled * Examine the feasibility of the I CAN intervention. (Phase I) * Examine the acceptability of the I CAN intervention. (Phase I) * Examine topic areas selected for action within participants' I CAN plans for action. (Phase I) Phase II - Effectiveness of intervention trial for Lung Cancer Screening - 400 participants to be enrolled * Determine whether the I CAN intervention will result in higher number of individuals who complete lung cancer screening compared to didactic educational control. (Phase 2 \[Effectiveness of intervention trial for lung cancer screening\]) * Evaluate whether the I CAN intervention improves adherence to recommended annual lung cancer screening follow-up among participants who initially received low dose computed tomography of the chest (LDCT) screening. (Phase 2 \[Effectiveness of intervention trial for lung cancer screening\]) * Assess whether the I CAN intervention results in different levels of lung cancer screening knowledge and self-efficacy compared to the control group. (Phase 2 \[Effectiveness of intervention trial for lung cancer screening\]) OUTLINE: Participants are assigned to 1 of 2 phases. Phase I - Participants attend an I CAN intervention workshop over 2 hours. Phase 2 - Community-based programs are randomized to 1 of 2 arms and participants are assigned to the arm to which their community-based program was randomized.

Interventions

PROCEDURECommunity Health Education

Receive I CAN intervention

BEHAVIORALTelephone Based Intervention

Receive coaching call

Sponsors

Roswell Park Cancer Institute
Lead SponsorOTHER
Merck Sharp & Dohme LLC
CollaboratorINDUSTRY
National Comprehensive Cancer Network
CollaboratorNETWORK

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Being over 18 years old * Able to participate in English

Exclusion criteria

* Unwilling or unable to follow protocol requirements

Design outcomes

Primary

MeasureTime frameDescription
Demand - Phase 1Up to 2 yearsFeasibility will be assessed through demand, which will be evaluated as the number of people enrolled and the demographics of participants. Descriptive analyses will be used.
Practicality - Phase 1Up to 2 yearsPracticality will be assessed through the percentage of participants who complete different aspects of the intervention. Descriptive analyses will be used.
Acceptability- Phase 1Up to 2 yearsAcceptability will be examined through post-intervention measures, including the Acceptability of Intervention Measure, Intervention Appropriateness Measure, and Feasibility of Intervention Measure. Descriptive analyses will be used.
Lung Cancer Screening UptakeUp to 2 yearsWill be assessed by determining if I CAN intervention results in higher number of individuals who complete lung cancer screening

Secondary

MeasureTime frame
Rate of follow up for Lung cancer screening6 months post screening (estimated to be 2 years)

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORElizabeth Bouchard

Roswell Park Cancer Institute

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 5, 2026